IFLR1000, a research firm of leading financial and business law firms and lawyers, published the results of its annual survey at the end of last month. The 2022 ranking also recognized the LEXTAL team, specifically in the field of financial and corporate law.
LEXTAL has been mentioned in the IFLR1000 rankings before. Last year, Ants Karu, the head of corporate law and transactions, was also given special recognition and was named as highly regarded. Customer feedback speaks for itself:
Our attorney Kaisa-Maria Kubpart and partner and attorney-at-law Kristi Sild wrote a guest chapter for the EQS Group’s Expert Guide on Whistleblowing Laws in the EU. The Guide focuses on implementing the EU Whistleblowing Directive in the EU Member States. While the Directive had to be transposed into national law by 17 December 2021, a deadline that most EU member states failed to meet, EQS Group worked with its expert partner network, including LEXTAL, across the EU to paint the most comprehensive picture possible of the situation across the continent in mid-2022.
On May 1, a novel vaccine insurance law came into force in Estonia. Under the new law, a patient or their relatives can apply for compensation for personal injury caused by severe vaccination-related complications. LEXTAL’s attorneys-at-law Olavi-Jüri Luik and Rauno Kinkar played a key role in drafting the vaccine insurance law (medicines act).
Below is an intro to why the new insurance model is necessary and also how to apply for compensation in case of side effects.
Why Vaccine Insurance?
Severe complications from vaccination are statistically infrequent. However, side effects still exist. The advantage of vaccine insurance is that it helps to reduce people’s fears about vaccination. To lessen these fears, vaccine insurance has been introduced in about 30 countries worldwide. The advantage of insurance is that a person does not have to enter into a dispute with a vaccine manufacturer who is economically more capable and as such a difficult opponent.
Our good customer Tuul Mobility, an electric scooter rental service provider, has taken a road to success in the capital markets and with the help of LEXTAL started a bond issue which they have also applied for trading on First North. More information about TUUL’s future plans can be found at: https://tuul.xyz/en/. Partner Kristi Sild and lawyer Kaisa-Maria Kubpart will help TUUL with the bond issue.
LEXTAL has been granted the status of a Certified Adviser on Nasdaq Tallinn First North market.
The role of a Certified Adviser is to guide companies through the application process and ensure they meet First North rules and requirements on a continuous basis.
CEE Legal Matters interviewed our attorney-at-law and partner, Kristi Sild. She discussed the COVID-19 situation in Estonia.
The safety of COVID-19 vaccines is very high – serious injuries are rare. For example, as of the morning of 22 November, more than 1.6 million doses of vaccine had been administered in Estonia, of which only 0.37% of doses (5950 notifications) were reported to the State Agency of Medicines regarding all possible side effects and vaccine ineffectiveness. There are even fewer reports – 237 – describing at least one serious suspected adverse reaction with a temporal relationship. The most common side effects are pain at the injection site, tiredness, and fever, which go away on their own within a few days.
Rauno Kinkar, attorney-at-law and attorney Henri Ratnik from LEXTAL law firm sent a warning letter to the heads of state. They criticized the planned changes in the regulation of cryptocurrency.
For several years in a row now, LEXTAL has been recognized by law students as one of the most attractive employers. This year, out of 242 employers (including public institutions), LEXTAL has been ranked as the fourth most attractive employer. In a category of law firms, LEXTAL has been ranked as the second most attractive law firm to work for.
